We respond to NICE draft decision to reject ribociclib with fulvestrant for use on the NHS

The National Institute for Health and Care Excellence (NICE) has today (10 April 2019) provisionally rejected breast cancer drug ribociclib in...

10 April 2019

We respond to report on clinical management of breast cancer in NHS Tayside

Health Improvement Scotland has issued a report into the clinical management of breast cancer in NHS Tayside which highlights local inconsistencies...

5 April 2019

We respond to NICE approval of abemaciclib with fulvestrant for use on the Cancer Drugs Fund

The National Institute for Health and Care Excellence (NICE) has today published draft guidance recommending breast cancer drug abemaciclib with...

2 April 2019

We respond to new analysis predicting UK breast cancer mortality rates are to improve in 2019

Mortality rates from breast cancer are predicted to fall in the UK and across Europe (except for in Poland) by 2019, according to new research...

19 March 2019

We respond to news that immunotherapy atezolizumab is to be made temporarily available to certain NHS breast cancer patients via early access scheme

New breast cancer immunotherapy atezolizumab (Tecentriq) is to be made available in the short term for certain NHS patients with metastatic ‘triple...

15 March 2019

We respond to monthly NHS England breast cancer waiting times: January 2019

New monthly cancer waiting times figures have been released today by NHS England. The figures show: The two week wait for people referred with...

14 March 2019

We respond to study showing that molecular patterns could better predict breast cancer recurrence

The study, led by scientists at the Cancer Research UK Cambridge Institute and published in Nature, examined the patterns of genetic changes within...

13 March 2019

We respond to proposed new NHS rapid care measures, including 28-day target for cancer diagnosis

NHS England has today announced that new waiting times standards for people with urgent mental and physical needs are to be trialled across the...

11 March 2019

We respond to report showing that attendance at breast screenings has fallen to new decade-low

The proportion of women aged 50-70 taking up routine breast screening fell to 70.5% in 2017-18, down from 71.1% in 2016-17, according to the Breast...

28 February 2019